Matched-pair, (86)Y/(90)Y-labeled, Bivalent RGD/Bombesin Antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a Potential Theranostic Agent for Prostate Cancer

INTRODUCTION: In this study, we describe development of a true matched-pair theranostic agent that is able to target the α(V)β(3) integrin and the gastrin releasing peptide receptor (GRPR). We herein describe methods to metallate and characterize the new conjugate and to validate its biological effi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nucl Med Biol
Autores principales: Bandara, Nilantha, Stott Reynolds, Tamila J., Schehr, Rebecca, Bandari, Rajendra P., Diebolder, Philipp J., Krieger, Stephanie, Xu, Jingli, Miao, Yubin, Rogers, Buck E., Smith, Charles J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6072280/
https://ncbi.nlm.nih.gov/pubmed/29929115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2018.06.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares